Cargando…
Challenges to Making the Decision to Stop Mass Drug Administration for Onchocerciasis: Lessons Learned from Nigeria
Autor principal: | Evans, Darin S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056426/ https://www.ncbi.nlm.nih.gov/pubmed/32043450 http://dx.doi.org/10.4269/ajtmh.19-0951 |
Ejemplares similares
-
Status of Onchocerciasis Transmission after More Than a Decade of Mass Drug Administration for Onchocerciasis and Lymphatic Filariasis Elimination in Central Nigeria: Challenges in Coordinating the Stop MDA Decision
por: Evans, Darin S., et al.
Publicado: (2014) -
Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions
por: Biamonte, Marco A., et al.
Publicado: (2022) -
Correction: Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions
por: Biamonte, Marco A., et al.
Publicado: (2023) -
Impacts of ivermectin mass drug administration for onchocerciasis on mosquito populations of Ogun state, Nigeria
por: Omitola, Olaitan Olamide, et al.
Publicado: (2021) -
The Interruption of Transmission of Human Onchocerciasis by an Annual Mass Drug Administration Program in Plateau and Nasarawa States, Nigeria
por: Richards, Frank O., et al.
Publicado: (2020)